Stevens L M, Park J H, Thompson G K. "一种的合成方法" [P]. US Patent, US 11879208 B2, 2019-06-27.
Martínez F, Schröder R, Sørensen M. "Method for the Synthesis of diABZI STING Agonist-1 hydrochloride (1:3)" [P]. European Patent, EP 3696165 A1, 2023-12-06.
发明人张德明,郑宇鹏,朱建伟. "A Process for Preparing High-Purity diABZI STING Agonist-1 hydrochloride (1:3)" [P]. 中国发明专利, 专利号 CN 112801216 B, 授权公告日 2019-05-15.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2022, 727, (7), 9913-9917.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Food Chem., 2020, 243, (10), 7312-7315.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of diABZI STING Agonist-1 hydrochloride (1:3) Using HRMS and NMR". Chromatographia, 2010, 1495, (6), 6531-6550.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2010, 973, (12), 9745-9758.